Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.
2.

Candida albicans SNO1 and SNZ1 expressed in stationary-phase planktonic yeast cells and base of biofilm.

Uppuluri P, Sarmah B, Chaffin WL.

Microbiology. 2006 Jul;152(Pt 7):2031-8.

PMID:
16804178
3.
5.

Preparation of RNA from unspheroplasted yeast cells (Saccharomyces cerevisiae).

McEntee CM, Hudson AP.

Anal Biochem. 1989 Feb 1;176(2):303-6.

PMID:
2662810
6.

Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.

Watamoto T, Samaranayake LP, Jayatilake JA, Egusa H, Yatani H, Seneviratne CJ.

Int J Antimicrob Agents. 2009 Oct;34(4):333-9. doi: 10.1016/j.ijantimicag.2009.03.008.

PMID:
19376687
7.
8.

The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.

Borecká-Melkusová S, Moran GP, Sullivan DJ, Kucharíková S, Chorvát D Jr, Bujdáková H.

Mycoses. 2009 Mar;52(2):118-28. doi: 10.1111/j.1439-0507.2008.01550.x.

PMID:
18627475
9.

Expression of TPK1 and TPK2 genes encoding PKA catalytic subunits during growth and morphogenesis in Candida albicans.

Souto G, Giacometti R, Silberstein S, Giasson L, Cantore ML, Passeron S.

Yeast. 2006 Jun;23(8):591-603.

10.

Morphogenesis control in Candida albicans and Candida dubliniensis through signaling molecules produced by planktonic and biofilm cells.

Martins M, Henriques M, Azeredo J, Rocha SM, Coimbra MA, Oliveira R.

Eukaryot Cell. 2007 Dec;6(12):2429-36.

11.

Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.

Chen CG, Yang YL, Tseng KY, Shih HI, Liou CH, Lin CC, Lo HJ.

Fungal Genet Biol. 2009 Sep;46(9):714-20. doi: 10.1016/j.fgb.2009.06.003.

PMID:
19527793
12.
13.

Methods for DNA extraction from Candida albicans.

Glee PM, Russell PJ, Welsch JA, Pratt JC, Cutler JE.

Anal Biochem. 1987 Jul;164(1):207-13.

PMID:
2823631
14.
15.

Change in the respiration system of Candida albicans in the lag and log growth phase.

Ogasawara A, Odahara K, Toume M, Watanabe T, Mikami T, Matsumoto T.

Biol Pharm Bull. 2006 Mar;29(3):448-50.

16.
17.

Inhibition of hyphae formation and SIR2 expression in Candida albicans treated with fresh Allium sativum (garlic) extract.

Low CF, Chong PP, Yong PV, Lim CS, Ahmad Z, Othman F.

J Appl Microbiol. 2008 Dec;105(6):2169-77. doi: 10.1111/j.1365-2672.2008.03912.x.

18.

A proteomic view of Candida albicans yeast cell metabolism in exponential and stationary growth phases.

Kusch H, Engelmann S, Bode R, Albrecht D, Morschhäuser J, Hecker M.

Int J Med Microbiol. 2008 Apr;298(3-4):291-318.

PMID:
17588813
19.

Transcriptional activation and increased mRNA stability contribute to overexpression of CDR1 in azole-resistant Candida albicans.

Manoharlal R, Gaur NA, Panwar SL, Morschhäuser J, Prasad R.

Antimicrob Agents Chemother. 2008 Apr;52(4):1481-92. doi: 10.1128/AAC.01106-07.

20.

Trehalose is an important mediator of Cap1p oxidative stress response in Candida albicans.

Cao Y, Wang Y, Dai B, Wang B, Zhang H, Zhu Z, Xu Y, Cao Y, Jiang Y, Zhang G.

Biol Pharm Bull. 2008 Mar;31(3):421-5.

Items per page

Supplemental Content

Support Center